The study conducted by Kuśnierz-Cabala et al. [63] also called attention to the use of galectin-3 in the diagnosis of pneumonia, particularly in situations of severe COVID-19 course. This evidence concerns the gene LGALS3 and susceptibility to pneumonia measurement.